IONS — ISIS PHARMACEUTICALS INC COM

Ownership history in Diversified Trust Co  ·  3 quarters on record

This page tracks every 13F SEC filing in which Diversified Trust Co reported a position in ISIS PHARMACEUTICALS INC COM (IONS). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.06% (2012 Q3)
Avg. % of fund
0.03%
First filed
2012 Q3
Last filed
2025 Q3
Quarters held
3
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2025 Q3 ADDED 15,633 +9,618 +159.9% 0.02% $1.0M $65.42
2024 Q1 REDUCED 6,015 -28,370 -82.5% 0.01% $261K $43.35
2012 Q3 INITIATED 34,385 — — 0.06% $484K —
% of Fund (quarterly)    IONS price (monthly, adj. close)

Other funds also holding IONS

As of 2025 Q4 — sorted by position size

Tweedy, Browne Co LLC 3Y 7Y 15.74% BOONE CAPITAL MANAGEMENT LLC 3Y 10.37% Bellevue Group AG 3Y 7Y 7.2% Tri Locum Partners LP 3Y 5.72% Orion Investment Co 5.43% Exome Asset Management LLC 4.41% Privium Fund Management B.V. 3Y 3.51% Sicart Associates LLC 3Y 7Y 3.43% SECTOR GAMMA AS 3Y 7Y 3.34% SUMMIT PARTNERS PUBLIC ASSET MANAGEMENT, LLC 3Y 7Y 2.41%
← Back to Diversified Trust Co Holdings